Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2771400 | Seminars in Arthritis and Rheumatism | 2011 | 17 Pages |
Abstract
The current study confirms the therapeutic efficacy of pregabalin and the SNRIs, duloxetine and milnacipran, in the treatment of fibromyalgia. Given their different modes of action, combination therapy with pregabalin plus an SNRI should be investigated in future research.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ernest MD, David MD, Zahava L. PhD, Stephen A. PhD, Elizabeth MSc, Helen A. MSc,